Hospitals at risk for hazardous pharmaceutical waste violations
"Two-thirds of U.S. hospitals are not fully compliant with EPA requirements," warned Tim Vanderveen, PharmD, vice president, CareFusion Center for Safety and Clinical Excellence, during a recent webinar, sponsored by CareFusion. "Pharmacists and pharmacy technicians can be held personally liable for violations in which they are involved."
Hospitals seldom set out to violate EPA provisions. They just don't realize that they are subject to EPA regulation, said Fred Massoomi, PharmD, pharmacy operations coordinator, Nebraska Methodist Hospital, Omaha, Neb. He became involved when the hospital was found in violation of EPA's Resource Conservation and Recovery Act (RCRA) regulations in 2004 for the EPA U-listed chemical cyclophosphamide waste handling and manifesting.
"A lot of what we do in pharmacy in terms of pharmaceutical waste practices is a legacy of concerning practices, like sewering of drug wastes, which is not the best practice to protect the public," he said. "There is a consequence to the ways we dispose of drugs. EPA has had healthcare on its radar for some time."
It's an easy target. In 2008, EPA estimated that hospitals produce about 12 million pounds of hazardous waste annually, Massoomi said. His hospital, with 400 licensed beds, has more than 459 separate locations at which hazardous pharmaceutical wastes can be generated.
Defining "hazardous waste"
The good news is that fewer than 5% of drugs qualify as hazardous waste (Table 1), said Lisa M. Lauer, an official with EPA Materials Recovery and Waste Management Division, Office of Resource Conversion and Recovery, Washington, D.C.
Drugs used for their intended purpose are not hazardous waste, Lauer said. A nicotine patch, which has been used on a patient as intended and then discarded, is not hazardous waste. But a nicotine patch that was discarded without being used is hazardous waste.
Drug containers can also be hazardous waste if they contain drug residue. Hospitals face a difficult choice, Lauer said. They can treat the containers as hazardous waste or triple rinse the containers and treat the rinsate as hazardous waste.
EPA has made some adjustments for healthcare, she added. Used syringes are not hazardous waste, for example. Warfarin residues less than 0.3% qualify for less stringent handling requirements. But almost any amount of hazardous waste can leave facilities subject to penalties that can mount into the hundreds of thousands of dollars.
EPA has a cradle-to-grave policy for hazardous waste handling that includes generation by hospital pharmacies and patient-care operations, transport by waste haulers, storage, and eventual treatment. Most states have their own hazardous waste programs, she added.
"EPA is setting the baseline for regulation," Lauer warned. "Some states are more stringent than federal regulations."
MORE ARTICLES IN THIS ISSUE
The outcry from physicians, pharmacists, and patients over disruptions in supplies of vital medications continues to draw attention on Capitol Hill and throughout the healthcare system.
Readers speak out about the title of "Dr." and pharmacies in Canada.
Requiring prior authorization may have a broader impact than expected.
Implementation of the "biosimilars" law is going well, but the exclusivity period seems to be a problem.
ASHP continues to make solving the drug shortages problem a top priority.